Mirodenafil - CAS# 862189-95-5 lifol A AZM475271 is orally Src tyrosine

AZM475271 is orally Src tyrosine kinase inhibitor with potential anticancer and antimetastatic activities

is a EGFR/DNA topoisomerase II inhibitor potentially for the treatment of bladder cancer and prostate

Chemical Name: 3-(4-hydroxyphenyl)-7-isopropoxy-4H-chromen-4-one

9-tetrahydro-5H-benzo[7]annulen-2-yl]-1H-1

Mirodenafil - CAS# 862189-95-5 lifol A AZM475271 is orally Src tyrosineMirodenafil, also known as SK3530, belongs to the drug class PDE5 inhibitors, which includes avanafil, sildenafil, tadalafil, udenafil, and vardenafil, and is the first line treatment for erectile dysfunction. Developed by SK Chemicals Life Science, mirodenafil is marketed in Korea under the trade name Mvix, offered both as tablets (50 mg and 100 mg) and as orally dissolving film (50 mg). Several clinical trials were conducted, but mirodenafil has not